Barclays lowered the firm’s price target on Emerson (EMR) to $99 from $105 and keeps an Underweight rating on the shares. The firm says short cycle industrial stocks “are starting to look more attractive” verses defensives, but adds that demand visibility is “very low.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Emerson price target lowered to $125 from $158 at KeyBanc
- Emerson price target lowered to $110 from $135 at JPMorgan
- Emerson relative weakness a buying opportunity, says Argus
- Emerson price target lowered to $105 from $110 at Barclays
- Reddit initiated, Netflix upgraded: Wall Street’s top analyst calls